<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Insurance Portfolio Insurance Portfolio — News on 6ix</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio</link>
<description>Latest news and press releases for Insurance Portfolio Insurance Portfolio on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/insurance-portfolio-insurance-portfolio" rel="self" type="application/rss+xml" />
<item>
<title>The Manitowoc Company Schedules First-Quarter 2026 Earnings Announcement and Conference Call</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/the-manitowoc-company-schedules-first-quarter-2026-earnings-announcement-and-conference-call-13</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/the-manitowoc-company-schedules-first-quarter-2026-earnings-announcement-and-conference-call-13</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>MILWAUKEE, Wis.--(BUSINESS WIRE)-- The Manitowoc Company, Inc. (NYSE: MTW) announced today that it will release its first-quarter 2026 results on Tuesday,</description>
</item>
<item>
<title>Wolfspeed, Inc. Announces Date of Fiscal Third Quarter Earnings Call for May 5, 2026</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/wolfspeed-inc-announces-date-of-fiscal-third-quarter-earnings-call-for-may-5-2026-3</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/wolfspeed-inc-announces-date-of-fiscal-third-quarter-earnings-call-for-may-5-2026-3</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>DURHAM, N.C.--(BUSINESS WIRE)-- Wolfspeed, Inc. (NYSE: WOLF), a global leader in silicon carbide technology, will conduct a conference call and audio webcast</description>
</item>
<item>
<title>F&M Bank Announces Appointment of Shalini Singhal to Chief Information and Technology Officer</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/fandm-bank-announces-appointment-of-shalini-singhal-to-chief-information-and-technology-officer-36</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/fandm-bank-announces-appointment-of-shalini-singhal-to-chief-information-and-technology-officer-36</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>ARCHBOLD, Ohio, April 21, 2026 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO),</description>
</item>
<item>
<title>Century Complete Announces Grand Opening in Alford, FL, Bringing Affordable New Homes to the Florida Panhandle</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/century-complete-announces-grand-opening-in-alford-fl-bringing-affordable-new-homes-to-the-florida-panhandle-14</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/century-complete-announces-grand-opening-in-alford-fl-bringing-affordable-new-homes-to-the-florida-panhandle-14</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>New one-story homes from the low $200s to begin selling in April at Compass Lake in the HillsALFORD, Fla., April 21, 2026 /PRNewswire/ -- Century Communities,</description>
</item>
<item>
<title>MONO Names Jeffrey Gorder CEO as Agency Enters Next Chapter of Growth and Transformation </title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/mono-names-jeffrey-gorder-ceo-as-agency-enters-next-chapter-of-growth-and-transformation-2</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/mono-names-jeffrey-gorder-ceo-as-agency-enters-next-chapter-of-growth-and-transformation-2</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>MINNEAPOLIS, MN / ACCESS Newswire / April 21, 2026 / MONO, the Minneapolis-based advertising and branding agency and part of the Stagwell network, today</description>
</item>
<item>
<title>Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/bicycle-therapeutics-announces-oral-and-poster-presentations-at-the-2026-asco-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/bicycle-therapeutics-announces-oral-and-poster-presentations-at-the-2026-asco-annual-meeting</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)-- Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of</description>
</item>
<item>
<title>Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/immatics-announces-four-upcoming-oral-presentations-across-its-clinical-cell-therapy-and-bispecific-portfolio-at-2026-asco-annual-meeting</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/immatics-announces-four-upcoming-oral-presentations-across-its-clinical-cell-therapy-and-bispecific-portfolio-at-2026-asco-annual-meeting</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>Houston, Texas and Tuebingen, Germany, April 21, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of</description>
</item>
<item>
<title>IDEAYA Biosciences Announces Late-Breaking Abstract Oral Presentation at ASCO 2026 to Provide Complete Data from Phase 2/3 Registrational Trial (OptimUM-02) of Darovasertib in Combination with Crizotinib in 1L HLA*A2-Negative Metastatic Uveal Melanoma</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/ideaya-biosciences-announces-late-breaking-abstract-oral-presentation-at-asco-2026-to-provide-complete-data-from-phase-23-registrational-trial-optimum-02-of-darovasertib-in-combination-with-crizotinib-in-1l-hlaa2-negative-metastatic-uveal-melanoma</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/ideaya-biosciences-announces-late-breaking-abstract-oral-presentation-at-asco-2026-to-provide-complete-data-from-phase-23-registrational-trial-optimum-02-of-darovasertib-in-combination-with-crizotinib-in-1l-hlaa2-negative-metastatic-uveal-melanoma</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>SOUTH SAN FRANCISCO, Calif., April 21, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today</description>
</item>
<item>
<title>Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic</title>
<link>https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/northwest-biotherapeutics-announces-establishment-of-the-companys-own-dedicated-leukapheresis-clinic-3</link>
<guid isPermaLink="true">https://6ix.com/company/insurance-portfolio-insurance-portfolio/news/northwest-biotherapeutics-announces-establishment-of-the-companys-own-dedicated-leukapheresis-clinic-3</guid>
<pubDate>Tue, 21 Apr 2026 04:00:00 GMT</pubDate>
<description>BETHESDA, Md., April 21, 2026 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing</description>
</item>
</channel>
</rss>